{"id":"https://openalex.org/W4388042467","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","title":"1162 Upregulation of metabolism enzymes mediatesADC resistance in a HER2-positive cancer cell line","display_name":"1162 Upregulation of metabolism enzymes mediatesADC resistance in a HER2-positive cancer cell line","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388042467","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1162"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1162","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1281.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4388042467"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1281.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100391510","display_name":"Dong Wang","orcid":"https://orcid.org/0000-0002-8340-2763","observed_orcids":["https://orcid.org/0000-0002-8340-2763"]},"institutions":[{"id":"https://openalex.org/I2799321762","display_name":"WuXi AppTec (China)","ror":"https://ror.org/04eh3ca90","country_code":"CN","type":"company","lineage":["https://openalex.org/I2799321762"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dong Wang","raw_affiliation_strings":["WuXi AppTec, Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WuXi AppTec, Inc., Shanghai, China","institution_ids":["https://openalex.org/I2799321762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057507617","display_name":"Xiangnan Qiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114173","display_name":"WuXi AppTec (United States)","ror":"https://ror.org/027jt8826","country_code":"US","type":"company","lineage":["https://openalex.org/I2799321762","https://openalex.org/I4210114173"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiangnan Qiang","raw_affiliation_strings":["WuXi AppTec, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WuXi AppTec, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210114173"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100626931","display_name":"Zhixiang Zhang","orcid":"https://orcid.org/0000-0002-1161-5065","observed_orcids":["https://orcid.org/0000-0002-1161-5065","https://orcid.org/0009-0007-3015-5854","https://orcid.org/0009-0005-6779-3046"]},"institutions":[{"id":"https://openalex.org/I2799321762","display_name":"WuXi AppTec (China)","ror":"https://ror.org/04eh3ca90","country_code":"CN","type":"company","lineage":["https://openalex.org/I2799321762"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhixiang Zhang","raw_affiliation_strings":["WuXi AppTec, Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WuXi AppTec, Inc., Shanghai, China","institution_ids":["https://openalex.org/I2799321762"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100552631","display_name":"Qingyang Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799321762","display_name":"WuXi AppTec (China)","ror":"https://ror.org/04eh3ca90","country_code":"CN","type":"company","lineage":["https://openalex.org/I2799321762"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qingyang Gu","raw_affiliation_strings":["WuXi AppTec, Inc., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"WuXi AppTec, Inc., Shanghai, China","institution_ids":["https://openalex.org/I2799321762"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1281","last_page":"A1281"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-gastric-cancer","display_name":"HER2-positive gastric cancer","score":0.8370000123977661},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7490000128746033},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.906000018119812},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6890000104904175},{"id":"https://openalex.org/keywords/metabolic-enzymes","display_name":"metabolic enzymes","score":0.5649999976158142},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.8140000104904175},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9990000128746033},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.546999990940094},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5905495285987854},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.587065577507019},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4455745220184326},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.44424548745155334},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.43784767389297485},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.43715861439704895},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.42487239837646484},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42403486371040344},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3949434161186218},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3158717751502991},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27634674310684204},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18298646807670593},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13293829560279846},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12007546424865723},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1162","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1281.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:d979c39b1ede4b15a3fd48b374be2423","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d979c39b1ede4b15a3fd48b374be2423","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1162","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1162","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1281.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388042467.pdf","grobid_xml":"https://content.openalex.org/works/W4388042467.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7148954596","https://openalex.org/W7148898141","https://openalex.org/W4405135268","https://openalex.org/W4411289334","https://openalex.org/W4393093809","https://openalex.org/W7148674181","https://openalex.org/W7148672054","https://openalex.org/W4409628442","https://openalex.org/W4409624407","https://openalex.org/W4401728730"],"abstract_inverted_index":{"Background":[0],"The":[1],"receptor":[2],"tyrosine":[3],"kinase":[4],"HER2":[5,120,183,218,253,344],"is":[6,17,26,53,181,193],"overexpressed":[7],"in":[8,154,170,207,229,262,307,374,377],"approximately":[9],"20%":[10],"of":[11,30,38,58,99,110,122,196,224,240,247,252,294,316,335,343,356,361,370],"breast":[12,62],"cancer,":[13,63],"and":[14,35,82,130,141,190,198,210,221,232,259,290,311,331,350,359,376],"its":[15],"amplification":[16],"associated":[18],"with":[19,60,103,112,284,305],"reduced":[20],"survival.":[21],"Enhertu,":[22,104],"also":[23,215],"named":[24],"DS8201a,":[25],"HER2-targeting":[27],"ADC":[28,80],"consisting":[29],"human":[31],"HER2-targeted":[32],"mAb":[33],"trastuzumab":[34],"a":[36,46,76],"derivative":[37],"DX-8951":[39],"(DXd),":[40],"which":[41,180,192],"are":[42],"bound":[43],"together":[44],"by":[45,117,127,147,267,275],"maleimide":[47],"glycynglycyn-phenylalanyn-glycyn":[48],"(GGFG)":[49],"peptide":[50],"linker.":[51],"Enhertu":[52,111,150,164,197,285,306,326],"approved":[54],"for":[55],"the":[56,89,194,217,222,227,238,313,333,368],"treatment":[57],"patients":[59],"HER2-positive":[61],"gastric":[64],"cancer":[65],"or":[66,107,281,302,364],"HER2-mutant":[67],"Non-Small":[68],"Cell":[69],"Lung":[70],"Cancer.":[71],"Acquired":[72],"resistance":[73,355,369],"has":[74],"been":[75],"major":[77],"obstacle":[78],"to":[79,96,178,202,286,354],"treatment,":[81],"mechanisms":[83],"remain":[84],"incompletely":[85],"defined.":[86],"Methods":[87],"In":[88,320],"present":[90],"study,":[91,322],"CellTiter-Glo":[92],"assay":[93],"was":[94,115,125,145,152,273],"used":[95],"detect":[97],"viability":[98],"tumor":[100,113,123,139,143,248,295,317,371],"cells":[101,114,124,167,173,209,231,358,372],"treated":[102],"T-DM1,":[105,179],"Dxd":[106,189],"DM-1.":[108],"Binding":[109],"determined":[116,146],"flow":[118,131],"cytometry.":[119,132],"expression":[121,134,219,251,271,342],"analyzed":[126],"western":[128],"blot":[129],"Gene":[133,270],"difference":[135,272],"between":[136],"drug":[137,241,336],"resistant":[138,165,177,327],"cell":[140,144,264,289,329],"parental":[142,211,233],"RNA":[148,245,268],"seq.":[149],"efficacy":[151],"measured":[153],"sub-cutaneous":[155],"N87":[156,166,212,234,309,328],"xenografts":[157],"after":[158],"intravenous":[159],"injection.":[160],"Results":[161],"We":[162,214,277],"established":[163,324],"(N87-R":[168],"cells)":[169],"vitro.":[171],"N87-R":[172,208,230,263,288,357],"displayed":[174],"no":[175],"cross":[176],"another":[182],"targeting":[184],"ADC.":[185],"Then":[186],"we":[187,243,298,323],"tried":[188],"DM-1,":[191],"payload":[195],"T-DM1":[199],"respectively.":[200],"Sensitivity":[201],"these":[203],"payloads":[204],"were":[205,226,265],"consistent":[206],"cells.":[213,235,249,296,318],"observed":[216],"level":[220],"kinetics":[223],"binding":[225],"same":[228],"To":[236],"investigate":[237],"mechanism":[239,334],"resistance,":[242],"conducted":[244],"seq":[246],"Increased":[250],"downstream":[254,345],"signals":[255,346],"containing":[256,347],"PI3K-AKT":[257,348],"signal":[258,261,349,352,363,366],"MAPK":[260,282,303,351,365],"demonstrated":[266],"sequencing.":[269],"confirmed":[274],"qPCR.":[276],"combined":[278,299],"PI3K":[279,300,362],"inhibitor":[280,283,301,304],"treat":[287],"found":[291,312],"increased":[292,314,341],"sensitivity":[293,315],"Finally,":[297],"subcutaneous":[308],"xenograft":[310],"Conclusions":[319],"this":[321],"an":[325],"line":[330],"investigated":[332],"resistance.":[337],"Our":[338],"results":[339],"showed":[340],"lead":[353],"inhibition":[360],"reversed":[367],"both":[373],"vitro":[375],"vivo.":[378]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4388042467","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2023-11-01T00:00:00"}
